AJR Am J Roentgenol
- BRAAT AJAT, Kim HC, Vogl TJ, White SB, et al
The Global Reading Room: A Patient With Neuroendocrine Liver Metastases After
Pancreaticoduodenectomy.
AJR Am J Roentgenol. 2023 Aug 23. doi: 10.2214/AJR.23.30113.
Am J Gastroenterol
- ARTZNER T, Goldberg DS, Sundaram V, Faitot F, et al
Improvement in survival after transplantation for critically ill patients with
cirrhosis in the United States.
Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002944.
- ASKGAARD G, Jepsen P, Jensen MD, Kann AE, et al
Population-Based Study of Alcohol-Related Liver Disease in England in 2001-2018:
Influence of Socioeconomic Position.
Am J Gastroenterol. 2024;119:1337-1345.
Ann Intern Med
- SIMON TG, Singer DE, Zhang Y, Mastrorilli JM, et al
Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in
Patients With Cirrhosis and Atrial Fibrillation : A Nationwide Cohort Study.
Ann Intern Med. 2024 Jul 9. doi: 10.7326/M23-3067.
BMC Cancer
- ZHU S, Jin Y, Zhou M, Li L, et al
KK-LC-1, a biomarker for prognosis of immunotherapy for primary liver cancer.
BMC Cancer. 2024;24:811.
- WIGG A, Tibballs J, Woodman R, Stuart K, et al
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early
Stage HepatoCellular Carcinoma (SOCRATES HCC).
BMC Cancer. 2024;24:813.
- WEI X, Yang C, Lin Q, Qiu M, et al
Associations between modifiable risk factors and hepatocellular carcinoma: a
trans-ancestry Mendelian randomization study.
BMC Cancer. 2024;24:820.
- ZENG J, Feng Y, Lin L, Ye H, et al
Circ_0000069 promotes the development of hepatocellular carcinoma by regulating
CCL25.
BMC Cancer. 2024;24:827.
BMC Gastroenterol
- ALKHOURI N, Almomani A, Le P, Payne JY, et al
The prevalence of metabolic dysfunction-associated steatotic liver disease
(MASLD)-related advanced fibrosis and cirrhosis in the United States population
utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017-2018 cycle.
BMC Gastroenterol. 2024;24:218.
- SUN J, Yan C, Wen J, Wang F, et al
Association between different obesity patterns and the risk of NAFLD detected by
transient elastography: a cross-sectional study.
BMC Gastroenterol. 2024;24:221.
Dig Dis Sci
- YAKUBU I, Flynn S, Khan H, Nguyen M, et al
Burden of Portal Hypertension Complications Is Greater in Liver Transplant
Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.
Dig Dis Sci. 2024 Jul 10. doi: 10.1007/s10620-024-08499.
- EDELSON JC, Rockey DC
Safety of Endoscopy in Cirrhosis.
Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
Eur Radiol
- PAN J, Huang H, Zhang S, Zhu Y, et al
Intraindividual comparison of CT and MRI for predicting vessels encapsulating
tumor clusters in hepatocellular carcinoma.
Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10944.
- WANG F, Zhang Q, Yan K, Jing X, et al
3D-CEUS/MRI-CEUS fusion imaging vs 2D-CEUS after locoregional therapies for
hepatocellular carcinoma: a multicenter prospective study of therapeutic
response evaluation.
Eur Radiol. 2024 Jul 11. doi: 10.1007/s00330-024-10915.
- RONOT M
Illuminating the shades of hyper- to isointense lesions in hepatobiliary phase
imaging.
Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10894.
- GU K, Jeong WK, Cha DI, Hwang JA, et al
Bile duct diffusion-weighted image hyperintensity predicts intrahepatic biliary
complications after ABO-incompatible liver transplantation.
Eur Radiol. 2024 Jul 9. doi: 10.1007/s00330-024-10914.
Gastroenterology
- LENS S
Resmetirom for Non-alcoholic Steatohepatitis.
Gastroenterology. 2024 Jun 25:S0016-5085(24)05120.
Gut
- LOOMBA R, Amangurbanova M, Bettencourt R, Madamba E, et al
MASH Resolution Index: development and validation of a non-invasive score to
detect histological resolution of MASH.
Gut. 2024;73:1343-1349.
- WANG Y, Heymann F, Peiseler M
Intravital imaging: dynamic insights into liver immunity in health and disease.
Gut. 2024;73:1364-1375.
Hepatology
- ZHANG L, Xie P, Li M, Zhang X, et al
Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and
inflammation by inducing CEACAM1 N153 fucosylation.
Hepatology. 2024 Jul 10. doi: 10.1097/HEP.0000000000001003.
- HUANG Y, Yu F, Ding Y, Zhang H, et al
Hepatic IL22RA1 deficiency promotes hepatic steatosis by modulating oxysterol in
the liver.
Hepatology. 2024 Jul 10. doi: 10.1097/HEP.0000000000000998.
- HOOVER JM
Letter to the Editor: Utilization of beta blockers in patients with portal
hypertension and peripheral artery disease.
Hepatology. 2024 Jul 8. doi: 10.1097/HEP.0000000000001008.
Indian J Gastroenterol
- BICHA S, Boumaraf H, Lakehal A
Shear wave elastography as a non-invasive tool for staging liver fibrosis in
children: A study in Algerian pediatric patients.
Indian J Gastroenterol. 2024;43:601-608.
- EKANAYAKA SPN, Luke N, Thilakarathne SB, Dassanayake A, et al
Characteristics and survival of advanced untreated hepatocellular carcinoma of
non-viral etiology.
Indian J Gastroenterol. 2024 Jul 10. doi: 10.1007/s12664-024-01636.
J Comput Assist Tomogr
- JEPH S, Gupta S, Yedururi S, Daoud TE, et al
Liver Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
J Comput Assist Tomogr. 2024;48:577-587.
J Gastroenterol Hepatol
- XIN Z, Chen H, Xu J, Zhang H, et al
Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion
in hepatocellular carcinoma.
J Gastroenterol Hepatol. 2024 Jul 7. doi: 10.1111/jgh.16677.
- SUGITA H, Nakanuma S, Munesue S, Ishikawa T, et al
Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal
obstruction syndrome.
J Gastroenterol Hepatol. 2024;39:1413-1421.
- LIU Y, Hu Y, Li B, Su R, et al
Innate lymphoid cell subsets in the pathogenesis of primary biliary cholangitis.
J Gastroenterol Hepatol. 2024 Apr 12. doi: 10.1111/jgh.16547.
- LEE RC, Liang PC, Liang HL, Chen YF, et al
Multicenter evaluation of the safety and efficacy of selective internal radiation
therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN
registry.
J Gastroenterol Hepatol. 2024;39:1318-1327.
- MALANDRIS K, Papandreou S, Vasilakou D, Kakotrichi P, et al
Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers
in patients with nonalcoholic fatty liver disease: systematic review and network
meta-analysis.
J Gastroenterol Hepatol. 2024;39:1219-1229.
- MORI K, Akiyama Y, Tanaka M, Sato T, et al
Deciphering metabolic dysfunction-associated steatotic liver disease: insights
from predictive modeling and clustering analysis.
J Gastroenterol Hepatol. 2024;39:1382-1393.
J Hepatol
- KWON Y, Gottmann P, Wang S, Tissink J, et al
Induction of steatosis in primary human hepatocytes recapitulates key
pathophysiological aspects of metabolic dysfunction-associated steatotic liver
disease.
J Hepatol. 2024 Jul 6:S0168-8278(24)02347-X. doi: 10.1016/j.jhep.2024.
PLoS Comput Biol
- WANG M, Yan X, Dong Y, Li X, et al
Machine learning and multi-omics data reveal driver gene-based molecular subtypes
in hepatocellular carcinoma for precision treatment.
PLoS Comput Biol. 2024;20:e1012113.
PLoS One
- CHANG JJ, Lin T, Jhang XY, Chan SP, et al
hnRNP Q/SYNCRIP interacts with LIN28B and modulates the LIN28B/let-7 axis in
human hepatoma cells.
PLoS One. 2024;19:e0304947.
Semin Liver Dis
- TINCOPA MA, Loomba R
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic
Dysfunction-Associated Steatotic Liver Disease and
Metabolic-Dysfunction-Associated Steatohepatitis.
Semin Liver Dis. 2024 Jul 9. doi: 10.1055/s-0044-1788277.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016